The Food and Drug Administration (FDA) has warned against the purchase or use of PNC-27, a product marketed as a treatment or cure for cancer. A laboratory analysis found the presence of Variovorax paradoxus, a bacteria, in a solution sample for inhalation.
PNC-27 has not been evaluated or approved by the FDA as safe and effective to treat any disease. It is promoted as a tiny, nontoxic protein molecule that attaches to specific receptors only found on cancer cells, causing them to die. Individuals who use a contaminated product are at risk for serious, potentially life-threatening infections. Patient groups at greater risk include young children, the elderly, pregnant women, and the immunocompromised.
PNC-27 is sold on the website PNC27.com and is supplied in different formulations, including a nebulized solution, intravenous solution, vaginal suppository, or rectal suppository. To date, the FDA has not received reports of illness or serious adverse events related to PNC-27.
For more information visit FDA.gov.